ÂÜÀòÂÒÂ×

Prior to joining PMV Pharma, Mr. Carulli was an Executive Director of R&D Financial Planning and Analysis at Celgene (now Bristol Myers Squibb) where he oversaw the financial and operational plans for the entire Research and Development organization. Over 10 years at Celgene he held multiple positions with increasing responsibility working closely on the R&D strategy, long range planning, and financial partnering to the Business Development and Alliance Management team. Mr. Carulli was the Chief of Staff to the President of Research & Early Development for 2 years, as well as the R&D finance lead for the Bristol Myers Squibb integration and Otezla divestiture to Amgen.

Combined, Mr. Carulli has over 20 years of financial management experience and has led many process improvement initiatives and implemented several business intelligence technology solutions. He received his MBA from Fordham University.